OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Neurology is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Transmembrane protein interacts with α-synuclein to confer risk of PD	448
Lymphatic propagation of α-synuclein	440
Promising results for antisense RNA therapy in mouse models of diffuse midline glioma	344
Brain stimulation aids walking after spinal injury	332
Reply to ‘Perils and pitfalls of near-death experience research’	327
ANA2025 marks important milestones for the ANA and NINDS	314
Genetic insights from Parkinson disease in African and African admixed populations	308
Nociceptive action of calcitonin gene-related peptide in the trigeminovascular system	271
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications	268
Neural cell state shifts and fate loss in ageing and age-related diseases	265
Global synergistic actions to improve brain health for human development	225
Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms	217
CD11c+ macrophages mediate brain-to-gut α-synuclein trafficking	201
Disease-specific modifications of tau protein	197
Continuous levodopa production by an artificial enzyme	183
TREM2 mediates phagocytosis in glioblastoma	178
SEQUINS — a new initiative to address disparities in neurology	172
Nir Giladi (1955–2024)	165
Spinal muscular atrophy treatment in utero	158
Rapidly progressive dementias — leukodystrophies as a potentially treatable cause	155
The Digitized Memory Clinic	150
Gut macrophages involved in Parkinson disease pathogenesis	150
Mitochondrial DNA instability in Huntington disease	142
The impact of rare genetic variants on Alzheimer disease	141
Imperatives and co-benefits of research into climate change and neurological disease	134

Psychosis-causing lesions mapped to a hippocampal circuit	133
The role of the gut microbiota in multiple sclerosis	133
Ultrasound lets gene therapy into the brain	113
Brain volume is associated with cognition in MS	111
Amyloid plaques: hotspots for microglial turnover	108
Challenges of combining multimodal data in assessment of people with traumatic brain injury	105
MRI-based deep learning for TLE diagnosis	100
Gene therapy for seizures in focal cortical dysplasia	99
Neurological care for LGBT+ people	95
First trials test targeting of α-synuclein for Parkinson disease	90
The challenges of anti-tau therapeutics in Alzheimer disease	89
Author Correction: Viral pathogens increase risk of neurodegenerative disease	88
Precision neuroimmunology in multiple sclerosis — the horizon is near	86
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice	85
Management of freezing of gait — mechanism-based practical recommendations	82
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis	80
Motor neuron disease in Africa: a critical appraisal of the literature	79
α-Synuclein pathology as a target in neurodegenerative diseases	79
Neuroinflammation predicts cognitive decline in FTD	79
Diversity, equity and inclusion in neurology	76
Parkinson disease pathology can originate in the kidney	76
Food is brain medicine — relevance and translation to neurology	74
Implications of AD plasma and PET biomarker discordance	74
Neurosteroids alleviate seizures in rats	73
Glymphatic dysfunction in PD clinical progression	71
A new biological classification for Parkinson disease	69
Addressing disparities in neurology by building the workforce in LMICs	69
Ultrasound ablation treatment for PD	64
Thalamic inflammation — a therapeutic target for brain injury?	61
New IDEAS about amyloid, race and dementia disparities	61
Post-COVID dysautonomias: what we know and (mainly) what we don’t know	59
Coeliac disease as a model for understanding multiple sclerosis	59
Spinal cord stimulation for the treatment of chronic pain	58
Skull bone marrow changes in multiple sclerosis	58